Calgary, AB – September 23, 2025 – TheNewswire - Universal Ibogaine Inc. (TSXV: IBO) OTC: IBOGF (the “Company”),  The Universal Ibogaine Board of directors brings together expertise in healthcare , clinical trials,  financial, and legal patient safety ensuring a strong foundation to guide the company through its next phase with confidence.As part of the transition, Peter Vlahos, Constantine Buzunis, Ken Cranwill, and Peter Ginakes will no longer be part of the Board of Directors and have resigned. Universa ...